An Industry Perspective on the Erice Declaration and Risk Minimisation Plans

By Ingate Simon   Tranter Deborah   Banerjee Anjan   Hobbs Andrew  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 733-734

Adis International

Access to resources Recommend Favorite

Drug safety communication: highlights from ISoP

By  

Reactions Weekly, Vol. 1, Iss. 1374, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

The Erice Manifesto: For Global Reform of the Safety of Medicines in Patient Care

By Adis International Limited  

Drug Safety, Vol. 30, Iss. 3, 2007-01 ,pp. : 187-190

Adis International

Access to resources Recommend Favorite

Effective Communication of Drug Safety Information to Patients and the Public: A New Look

By Vogt E.M.  

Drug Safety, Vol. 25, Iss. 5, 2002-01 ,pp. : 313-321

Adis International

Access to resources Recommend Favorite

Data Safety Monitoring Boards: Their Role in Drug Development and Pharmaceutical Trials

By Boardman H.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 39-46

Adis International

Access to resources Recommend Favorite